Knight Therapeutics, Inc. (KHTRF) Q1 2024 Earnings Call Transcript | Old North State Wealth News
Connect with us

Investing

Knight Therapeutics, Inc. (KHTRF) Q1 2024 Earnings Call Transcript

Published

on

Knight Therapeutics, Inc. (OTCPK:KHTRF) Q1 2024 Earnings Conference Call May 9, 2024 8:30 AM ET

Company Participants

Samira Sakhia – President & CEO
Amal Khouri – CBO
Arvind Utchanah – CFO

Conference Call Participants

Andre Uddin – Research Capital
Rahul Sarugaser – Raymond James
Scott McAuley – Paradigm Capital
Doug Miehm – RBC Capital Markets

Operator

Good morning, ladies and gentlemen. My name is Liz and I will be your operator today. Welcome to Knight Therapeutics First Quarter 2024 Results Conference Call.

Before turning the call over to Samira Sakhia, President and CEO of Knight, listeners are reminded that portions of today’s discussion may by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements.

The company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the company and its subsidiaries may ultimately prove to be incorrect.

The company disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events, except as required by law. We would also like to remind you questions during today’s call will be taken from analysts only. Should there be any further questions, please contact Knight’s Investor Relations department via email to info@knighttx.com or via phone at (514) 484-4483. I would like to remind everyone that this call is being recorded today, May 9, 2024.

And I would now like to turn the meeting over to your host for today’s call, Samira Sakhia. Please go ahead, Ms. Sakhia.

Samira Sakhia

Thank you, Liz. Good morning, everyone, and welcome to Knight Therapeutics first quarter 2024 conference call. On today’s call, I am joined by

Read the full article here

Trending

Copyright © 2022 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.